SCHEMBL30845757

SCHEMBL30845757

NC(=O)c1cn2c(n1)CC(c1ccccc1)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.43
RIPK1 Q13546 1/20 0.43
SIGMAR1 Q99720 1/20 0.39
KDM4E B2RXH2 2/20 0.39
SLC18A3 Q16572 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HCAR2 Q8TDS4 1/20 0.38
ATM Q13315 1/20 0.38
DHFR P00374 1/20 0.38
SCD5 Q86SK9 1/20 0.38
NAMPT P43490 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
IDO1 P14902 1/20 0.37
POLB P06746 2/20 0.36
GAA P10253 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21033243 0.89 RIPK1 (0.44) SCDRIPK1SIGMAR1SLC18A3NPC1
SCHEMBL21033480 0.81 RIPK1 (0.46) RIPK1KDM4ESLC18A3NPC1RAB9A
SCHEMBL30845782 0.80 ADRA1A (0.51) SCDRIPK1KDM4ENPC1RAB9A
SCHEMBL30845765 0.76 GRM2 (0.35) RIPK1KDM4ENAMPTHSD17B10ALDH1A1
SCHEMBL30845763 0.71 ALDH1A1 (0.39) RIPK1KDM4ENPC1RAB9ANAMPT
SCHEMBL21001668 0.71 PRMT5 (0.52)
SCHEMBL3664098 0.69 ADRA1A (0.54) SCDRIPK1NPC1RAB9AHCAR2
SCHEMBL12115086 0.67 DHFR (0.47) SCDDHFRSCD5
SCHEMBL4090031 0.66 HDAC1 (0.50) KDM4ENPC1RAB9ANAMPTGAA
SCHEMBL5490962 0.66 KCNH2 (0.56) SCDSIGMAR1SLC18A3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111542523-B Heterocyclic compounds as PRMT5 inhibitors 朱比连特埃皮斯科瑞有限责任公司 2024-03-29 CN claimed
CN-111542523-B Heterocyclic compounds as PRMT5 inhibitors 朱比连特埃皮斯科瑞有限责任公司 2024-03-29 CN disclosed